Epinephrine is under development for the treatment of allergic reactions, including anaphylaxis and allergic rhinitis. It is administered through nasal route in the form of powder. The drug candidate ...
Tasipimidine is under clinical development by Orion and currently in Phase I for Unspecified Psychiatric Disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback